These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14736432)

  • 1. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation.
    Chandra HR; Goldstein JA; Choudhary N; O'Neill CS; George PB; Gangasani SR; Cronin L; Marcovitz PA; Hauser AM; O'Neill WW
    J Am Coll Cardiol; 2004 Jan; 43(2):169-75. PubMed ID: 14736432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is aortic sclerosis associated with adverse clinical outcomes?
    Otto CM
    J Am Coll Cardiol; 2004 Jan; 43(2):176-8. PubMed ID: 14736433
    [No Abstract]   [Full Text] [Related]  

  • 3. C-reactive protein in predicting coronary artery disease in subjects with aortic valve sclerosis before diagnostic coronary angiography.
    Hsu SY; Hung KC; Chang SH; Wen MS; Hsieh IC
    Am J Med Sci; 2006 May; 331(5):264-9. PubMed ID: 16702796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic valve sclerosis is associated with systemic endothelial dysfunction.
    Poggianti E; Venneri L; Chubuchny V; Jambrik Z; Baroncini LA; Picano E
    J Am Coll Cardiol; 2003 Jan; 41(1):136-41. PubMed ID: 12570956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.
    Otto CM; Lind BK; Kitzman DW; Gersh BJ; Siscovick DS
    N Engl J Med; 1999 Jul; 341(3):142-7. PubMed ID: 10403851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of occurrence of aortic sclerosis in an aging population.
    Ngo DT; Sverdlov AL; Willoughby SR; Nightingale AK; Chirkov YY; McNeil JJ; Horowitz JD
    JACC Cardiovasc Imaging; 2009 Aug; 2(8):919-27. PubMed ID: 19679278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonobstructive aortic valve calcification: a window to significant coronary artery disease.
    Adler Y; Vaturi M; Herz I; Iakobishvili Z; Toaf J; Fink N; Battler A; Sagie A
    Atherosclerosis; 2002 Mar; 161(1):193-7. PubMed ID: 11882332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.
    Arroyo-Espliguero R; Avanzas P; Quiles J; Kaski JC
    Atherosclerosis; 2009 May; 204(1):239-43. PubMed ID: 18823889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Average Aortic Valve Sclerosis Score Index as a Marker for Significant Coronary Artery Disease in Patients with Non-ST-Elevation Myocardial Infarction or Unstable Angina.
    Nabati M; Favaedi M
    J Heart Valve Dis; 2018 Jan; 27(1):1-8. PubMed ID: 30560593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant coronary artery bypass graft and aortic and mitral valve replacement for rheumatic heart disease: short- and mid-term outcomes.
    Davarpasand T; Hosseinsabet A; Jalali A
    Interact Cardiovasc Thorac Surg; 2015 Sep; 21(3):322-8. PubMed ID: 26025595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of concomitant aortic valve replacement and coronary artery bypass grafting in the VA population.
    Alsoufi B; Karamlou T; Slater M; Shen I; Ungerleider R; Ravichandran P
    J Heart Valve Dis; 2006 Jan; 15(1):12-8; discussion 18-9. PubMed ID: 16480007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
    Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
    BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of plaque echolucency in combination with inflammatory biomarkers on cardiovascular outcomes of coronary artery disease patients receiving optimal medical therapy.
    Ishizu T; Seo Y; Machino T; Kawamura R; Kimura T; Murakoshi N; Sato A; Takeyasu N; Watanabe S; Aonuma K
    Atherosclerosis; 2011 May; 216(1):120-4. PubMed ID: 21353222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of an Echocardiographic Composite Cardiac Calcium Score to Predict Death in Patients With Stable Coronary Artery Disease (from the Heart and Soul Study).
    Saha SA; Beatty AL; Mishra RK; Whooley MA; Schiller NB
    Am J Cardiol; 2015 Jul; 116(1):50-8. PubMed ID: 25963223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic sclerosis--a marker of coronary atherosclerosis.
    Prasad Y; Bhalodkar NC
    Clin Cardiol; 2004 Dec; 27(12):671-3. PubMed ID: 15628107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery calcification outperforms thoracic aortic calcification for the prediction of myocardial infarction and all-cause mortality: the Heinz Nixdorf Recall Study.
    Kälsch H; Lehmann N; Berg MH; Mahabadi AA; Mergen P; Möhlenkamp S; Bauer M; Kara K; Dragano N; Hoffmann B; Moebus S; Schmermund A; Stang A; Jöckel KH; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1163-70. PubMed ID: 23467675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.
    Novaro GM; Katz R; Aviles RJ; Gottdiener JS; Cushman M; Psaty BM; Otto CM; Griffin BP
    J Am Coll Cardiol; 2007 Nov; 50(20):1992-8. PubMed ID: 17996566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in sudden late death by concomitant revascularization with aortic valve replacement.
    Czer LS; Gray RJ; Stewart ME; De Robertis M; Chaux A; Matloff JM
    J Thorac Cardiovasc Surg; 1988 Mar; 95(3):390-401. PubMed ID: 3343849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.